Roivant Sciences Ltd.

NASDAQ (USD): Roivant Sciences Ltd. (ROIV)

Last Price

10.84

Today's Change

+0.14 (1.30%)

Day's Change

10.65 - 10.85

Trading Volume

4,303,651

Overview

Market Cap

7 Billion

Shares Outstanding

727 Million

Avg Volume

4,781,681

Avg Price (50 Days)

11.67

Avg Price (200 Days)

11.38

PE Ratio

1.96

EPS

5.54

Earnings Announcement

10-Feb-2025

Previous Close

10.70

Open

10.77

Day's Range

10.655 - 10.85

Year Range

9.76 - 13.055

Trading Volume

4,303,651

Price Change Highlight

1 Day Change

1.31%

5 Day Change

-5.00%

1 Month Change

-7.27%

3 Month Change

-7.03%

6 Month Change

5.24%

Ytd Change

-10.26%

1 Year Change

8.18%

3 Year Change

53.76%

5 Year Change

4.23%

10 Year Change

4.23%

Max Change

4.23%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment